(Q54423436)

29 May 2018

title

Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. (English)

1 reference

29 May 2018

0 references

3

1 reference

29 May 2018

Hui Chen Wang

5

Hui-Chen Wang

1 reference

29 May 2018

Hung Cheng Lai

1

Hung-Cheng Lai

1 reference

29 May 2018

Yu Ping Liao

6

Yu-Ping Liao

1 reference

29 May 2018

Po Hsuan Su

7

Po-Hsuan Su

1 reference

29 May 2018

author name string

Ya-Wen Lin

2

1 reference

29 May 2018

Ming-Tzeung Chung

4

1 reference

29 May 2018

Yung-Liang Liu

8

1 reference

29 May 2018

Mu-Hsien Yu

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 September 2010

1 reference

29 May 2018

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

29 May 2018

volume

116

1 reference

29 May 2018

issue

18

1 reference

29 May 2018

page(s)

4266-4274

1 reference

29 May 2018

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

Cervix cancer death rates and mass cytologic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Pap smear screening and changes in cervical cancer mortality in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Cervical cancer in Canada: changing patterns in incidence and mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

The case for early detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Meta-analysis of Pap test accuracy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

The natural history of cervical HPV infection: unresolved issues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

HPV screening for cervical cancer in rural India

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

The power and the promise of DNA methylation markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

What will it take to obtain DNA methylation markers for early cervical cancer detection?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Epigenetic alterations in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Identification of novel DNA methylation markers in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Detection of hypermethylated genes in women with and without cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Characterization of LMX-1A as a metastasis suppressor in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

DNA methylation analysis in liquid-based cytology for cervical cancer screening.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Prior cone biopsy: prediction of preterm birth by cervical ultrasound.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Treatment for cervical intraepithelial neoplasia and risk of preterm delivery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Management of cervical intraepithelial neoplasia 2 in adolescent and young women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Natural history of dysplasia of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

2006 consensus guidelines for the management of women with abnormal cervical screening tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25252

7 January 2021

Identifiers

DOI

10.1002/CNCR.25252

1 reference

29 May 2018

1 reference

29 May 2018